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Abstract
Background: Early referral forms a crucial part in early inflammatory/rheumatoid
arthritis (EI/RA) recovery. Delayed decisions to refer can lead to severe incapacity
and emotional distress for individuals and family and feelings of lost time. How
patients with EI/RA experience early referral decisions in Primary Care is an under
explored area and warrants further investigation.
Aim: To explore how patients newly diagnosed with EI/RA experienced their early
contacts with Primary Care as they negotiated their journey through the referral
process into secondary care.
Design and setting: Qualitative face‐to‐face interviews with newly diagnosed EI/RA
patients.
Methods: In‐depth semi‐structured interviews were conducted to explore patients’
experiences of referral from first symptoms to General Practitioner referral. All
participants were interviewed within 2 weeks of being diagnosed in Secondary Care.
Data analysis was conducted using interpretative phenomenological analysis.
Findings: All participants in this study described having experienced struggles with
their navigation through Primary Care towards diagnosis and specialist EI/RA ser-
vices. This struggle comprised five key elements: ‘family persuasion’, ‘lack of con-
tinuity in care’, ‘pushing for referral’, ’strained relations’ and ‘lost time’.
Conclusion: The delays experienced by patients when attempting to reach an early
referral decision in Primary Care cause frustration for those presenting with EI/RA,
partly because they do not feel heard. There is a significant impact on patients and
their families when referral to specialist care is delayed.
K E Y W O R D S
delays, early inflammatory, patient experiences, primary care, rheumatoid arthritis
1 | INTRODUCTION
International guidance for early inflammatory/rheumatoid arthritis
(EI/RA) recommends an intense, targeted approach (De Wit
et al., 2011; Deighton et al., 2009; Singh et al., 2012; Smolen
et al., 2017). The 12‐week time period between first symptom onset
and treatment initiation for patients with EI/RA has been referred to as
a ‘therapeutic window of opportunity’ (Van Nies et al., 2015). This
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‘window’ is considered the optimal time for prompt disease manage-
ment: to achieve remission, improve long‐term clinical outcomes and
reduce risks of joint damage (Bykerk & Emery, 2010; Stack et al., 2019;
Van der Linden, 2010). The time it takes for a patient with early
symptoms to navigate their way through Primary Care to a General
Practitioner (GP) initiated referral to specialist rheumatology services
is crucial in meeting this therapeutic window.
There are three key factors on which timely referral and meeting
the window of opportunity are dependent (Sheppard et al., 2008).
These include
1. Patient factors: the time it takes for a patient to consult with a
GP.
2. Primary care factors: the time it takes for GPs to refer their pa-
tient to a specialist service.
3. Secondary care factors: the time it takes for a patient to be seen
following referral.
Of these three key factors, the time it takes for GPs to refer their
patient to a specialist has most recently been identified as the largest
contributor to overall delay (Stack et al., 2019).
The National Clinical Audit of Rheumatoid and Early Inflamma-
tory Arthritis report (2015) identified 20% of EI/RA patients were
referred within 3 working days of their GP appointment, with 25%
waiting more than 3 months.
‘The State of Play in UK Rheumatology’ (British Society of Rheu-
matology, 2015) identifies a lack of condition awareness amongst some
GPs as a contributor in referral delay. There is also recognised disparity
between clinicians and patient interpretations of shared decision‐
making (SDM), important in collaborative care. Delays are associated
with avoidable complications, for example, unbearable pain, disability,
anxiety and can negatively impact on patient–professional relation-
ships (Deighton et al., 2009 & Murray, 2002). The National Institute for
Health and Care Excellence (National Clinical Guideline Centre, 2012)
clinical guidance (cg138), highlights that professional–patient re-
lationships and patient‐centred care are both strengthened by pro-
fessionals identifying patient health needs, beliefs and preferences.
SDM describes a therapeutic approach whereby two experts (patients
and clinicians) make decisions collaboratively (Coulter & Collins, 2011;
Elwyn et al., 2012). It represents a middle ground between paternalistic
approaches to health care decision‐making (whereby the physician
makes decisions) and informed choice approaches (whereby patients
make decisions) (Charles et al., 1997, 1999; Elwyn et al., 1999). SDM
hasbeenassigned asan important collaborative approach tocare for all
adult NHS services for patients living with long‐term conditions,
including rheumatological conditions (Diederik et al., 2019; National
Institute for Health and Clinical Excellence Guideline, 2018; Sanderson
et al., 2019).
Given the important role of both patient and Primary Care
factors in relation to early intervention for EI/RA, the adoption of
SDM within primary consultations could play a role in reducing
treatment delay by facilitating open discussion of key concerns and
a consultation outcome which involves full participation and
agreement from both the patient and GP. However, to date, there is
minimal evidence available exploring these Primary Care factors for
referral delay, specifically from the patients’ perspective. When
considering referral from Primary Care to Secondary Care, it is
generally acknowledged that patient involvement is important
(Butterworth & Campbell, 2014; NICE, 2018; Sanderson
et al., 2019). How patient and GP share in decision‐making from the
first contact through the transition towards a referral decision,
potentially holds solutions to earlier referral into Secondary Care,
improving the window of opportunity.
This research forms part of a larger, longitudinal PhD study
which has been designed to explore SDM within rheumatology in
Secondary Care across four time points (first contact, 3, 6 and 12
months). The focus of this particular phase of the study was to
explore Primary Care factors in relation to early referral decisions to
Secondary Care. This included exploring patient endeavours in
seeking resolve for early symptoms, as well as their experiences in
relation to seeking referral by their GP, including any factors deemed
to hinder early referral.
2 | STUDY DESIGN
Given the lack of research currently available and the exploratory
nature of the study, a qualitative design was selected. A semi‐
T A B L E 1 Interview guide� In as much detail as possible can you describe your journey from your first symptoms to
when you were referred by your GP.
� [explore patient feelings].
� In what ways, if any, have family supported you?
� How long did you have symptoms before seeing your GP?
� How many times to you go and see your GP? How many GPs did you see regarding your
problem?
� What, in your opinion, were the factors that influenced the decision to refer?
� Explore involvement in the consultation.
Note: The significance of italics were prompts that the interviewer may have wished to explore
further with participants during interview.
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structured interview schedule (see Table 1) was developed and refined,
with assistance from South Warwick Foundation Trust patient forum
members, to guide the interviews, but they remained participant‐led to
allow material to emerge as relevant to participants experiences.
Interpretative Phenomenological Analysis (Smith et al., 2009) was
selected as the research approach and method for data analysis, given
the priority placed on individual participant experiences and the role of
the double hermeneutic. The double hermeneutic is applied when the
researcher actively acknowledges the role of their own interpretations
and experiences when seeking to uncover participant interpretations
of an experience (Reidet al., 2005). The explicit roleof the researcher in
forming interpretations based on their own experiences assumed
particular importance in this study as the lead researcher (Frances
Chilton [FC]) is an experienced rheumatology research and clinical
nurse specialist, bringing years of experience working with this patient
population within a Secondary Care environment.
3 | METHOD
3.1 | Sampling and recruitment
The study was granted NHS Ethics approval (NHS Ethical approval
reference 15/WM/0168) as well as R&D approval within the recruit-
ment site. Recruitment was conducted from within two hospital
outpatient departments, based within a large NHS Acute Trust within
the West Midlands region.
Prior to the study commencing, all six rheumatologists at the
participant site agreed to identify potential recruits to the study. The
lead researcher held an information session to overview the aims and
objectives for the study, then provided copies of the inclusion/
exclusion study criteria (See Table 2). These were available in all
rheumatology outpatient consultation rooms as reminders.
Potential participants were identified and approached about the
study towards the close of their initial consultation with their
Rheumatologist. This involved sharing brief information about the
study and asking for verbal consent from patients for the lead
researcher to make contact by phone and provide additional study
information. Contact was made by the lead researcher within 48 h of
this consent to approach and confirm agreement to enter the study.
Interviews were offered either at the hospital site or at home,
according to participant preference. Although the interviews were
conducted 1‐2‐1 (participant‐interviewer), participants could be
accompanied by a family member/next of kin if they preferred. All
participants were interviewed for up to and no longer than 1 h, on
the hospital site and three participants chose to be accompanied.
3.2 | Sample
A purposive sampling approach was adopted to recruit individuals
presenting with EI/RA symptoms for the first time in Secondary Care,
with specific focus on exploration and interpretation of participant
experiences. Fifteen patients were referred to the lead researcher.
One of these did not fulfil the inclusion criteria and three declined to
participate. Eleven patients consented to participate in the study (See
Table 3 for participant descriptors). All are identified by pseudonyms.
None of the participants attended the same GP surgery and so the
participant experiences reflected eleven different GP practices.
As the study progressed, it became clear that a prominent aspect
of EI/RA care was the experience of delays between Primary and
Secondary Care. Seven of the eleven participants in the study
described experiencing delays at this point of their care. The findings
from these seven participants are highlighted through this study to
enable an in‐depth understanding of the perceived reasons and
T A B L E 2 Inclusion/exclusion criteria
Inclusion/exclusion criteria
• Adults 18 years and over
• Individuals who were being referred into rheumatology department from primary care
for the first time and subsequently diagnosed with EIA/RA.
• Individuals who were English speaking and able to provide written informed consent.
• Individuals who had not taken immunosuppressive therapies before, such as disease
modifying anti‐rheumatic drugs (DMARDS).
Abbreviations: EIA/RA, early inflammatory/rheumatoid arthritis; DMARDS, disease modifying anti‐
rheumatic drugs.
T A B L E 3 Participant descriptors
Name Gender Age Diagnosis (Sero positive +/Negative −)
Alice* F 50 years RA+
Bev* F 72 years RA+
Carol* F 59 years RA+
Doris* F 69 years RA–
Eddy M 70 years EIA–
Freda F 44 years RA–
George* M 71 years RA–
Henry M 61 years RA+
Ian* M 53 years EIA+
Janice* F 45 years RA+
Karen F 53 years EIA–
*Seven of the 11 participants experienced delays between Primary and
Secondary Care.
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impact of delay to patients and their family members. These partic-
ipants are highlighted by * from the whole sample in Table 3.
3.3 | Analysis of findings
Interviews were transcribed verbatim by FC, the audio recordings
were then deleted as required by the relevant data management
policy. All analyses were undertaken by FC, as per Interpretative
Phenomenological Analysis (Smith et al., 2009) with support and
confirmation from supervisory team. The first stage of analysis
involved reading and re‐reading the transcripts so as to become
familiar with narratives. From initial notes, emergent themes were
developed to reflect early understandings from the data. As analysis
progressed, recurrent, interconnected subordinate themes were
identified. At the final stage of analysis, a single ‘master theme’ was
developed which reflected findings from the subordinate themes. The
master theme was titled ‘Navigational Struggles’.
Findings: The Master theme, Navigational struggles, reflects
participants early contact with Primary Care as they negotiated their
journey through the referral process into Secondary Care. Five sub-
ordinate themes encompass the master theme: persuasion of family,
lack of continuity in care, pushing for referral, strained relations and lost
time (See Figure 1). These will now be presented in turn.
3.4 | Persuasion of family
All participants considered their family and friends to have been
influential in their journey to referral. They provided direction and
support by influencing participants to confront their symptoms and
persuaded them to seek medical opinion;
No, if it was up to me, I still wouldn’t be here now. I’d still
be taking the pain killers. Oh, everybody has influenced
me, it’s not just the family it’s my customers (Ian).
This persuasion from family and friends appeared to be gener-
ated out of concern towards the symptoms being experienced by
participants, which were commonly causing physical limitations and
impacting on daily life. The impact of symptoms was not limited to
participants, but impacted on their family members, a key reason why
many family remained persistent when encouraging participants to
seek medical help:
I’ve got a 15 year old daughter at home and obviously
she does what she can for me but she has her own life.
So, my main support has been my husband and he
really helps me with everything (Janice).
When participants had consulted with GPs, family and friends
continued to seek involvement and information about next steps and,
where referrals had not yet been made, encouraged their family
member to persist:
My daughter is a nurse in A+E…I kept her informed
and she said I think a referral is asked for to be quite
honest (George).
3.5 | Lack of continuity in care
All seven participants expressed frustration that they were often
required to see a different GP at each visit, rather than a single,
preferred GP. Participants shared their views that this disruption to
F I G U R E 1 Process of analytical
development
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continuity of care had prolonged their journey to referral and caused
them to make multiple appointments in an attempt to resolve their
ongoing symptoms and resulting in different medical decisions and
suggested diagnoses which prolonged their journey to referral:
I saw three different GPs at different times and they did
blood tests and sent me for an x‐ray. They didn’t seem to
come up with much and then on the final time that I saw
someone my wrist was also beginning to swell and be
painful and he decided to refer me to the clinic. …. (Bev).
I suppose the first time you hope it will just go, that was
the first time they puffed up and I had the pills and
thought oh that was it., it didn’t improve really did it
erm, the second time I don’t know really…but by the
final one (GP)we found a bit more than we were
looking for you know we found the answers a bit more
I think by Dr Cxxx (George).
This led to participants reporting feelings of confusion, frustra-
tion and anxiety in relation to their ongoing symptoms. For some,
anxiety and frustration were caused by symptoms worsening, for
others, they felt their symptoms were being dismissed and they were
perceived to be a ‘nuisance patient’
so I felt a bit off mentioning it, that I was a bit of a
nuisance and you know…their time is precious and I
was totally unimportant (Carol).
We were going back and forth oh, 2–3 weeks in be-
tween, probably on a weekly basis because we knew
something was wrong because at our practice you can’t
see the same Dr unless you make an appointment
3 weeks/4 weeks ahead, and we weren’t seeing the
same person (George).
3.6 | Pushing for referral
Not feeling listened to, often despite worsening symptoms, was a key
cause of frustration for participants and their family members;
I think if I hadn’t been referred when I was then I would
have pushed for me to be referred because I felt that I
had gone long enough with trying different things. …I
felt frustrated because I could see that it was spreading
and getting worse, YES, and my husband was as con-
cerned really because he could see, that things were
progressing and not getting any better… (Bev).
Through this journey, participants were required to remain
persistent in seeking help, given the ongoing nature of their
symptoms;
I did say I ache all the time, I’m tired all the time,
which I’d been to the Drs for many a year and I’d
been saying this sort of thing. In the end the con-
dition just got worse and worse and all my joints
were aching and I was staring to not function
properly (Carol).
I had to push for it (referral) because I kept on since
last year I was suffering with these symptoms, which
have been going on now for over 1 year, now, so I do
have to constantly keep going down to the Dr’s with
the same symptoms and because my left ankle and
right hand were swollen that’s when he referred me
(Alice).
There was little evidence of meaningful patient participation
through this process, with participants feeling marginalised through
the referral decision‐making process;
So I went to the Dr and I asked if it could possibly be
Rheumatoid Arthritis, So she did the blood tests and
they came back negative and so that was negated, I just
couldn’t understand it (Doris).
3.7 | Strained relations
Participants who expressed a lack of continuity in care, reported
indifferent responses from their GPs which included disinterest and
negative attitudes. Responses included reports of not being taken
seriously;
I’d been to the Drs before and they had picked out
swelling that I’d got on my joints and a different Dr
would say oh, that’s just arthritis in a way that was
Oh… that’s just not taken seriously (Carol).
Participants commonly felt dismissed within Primary Care and
left with the perception that their symptoms were considered trivial;
He just wasn’t interested. Erm…… No. It was one of the
Drs at the surgery he just said nothing wrong, change
your pillows and your 10 min is up go. That’s the sort of
feeling you get with some of them and even then, I can
remember, my ankles had started to swell (Doris).
These experiences led to participants feeling their relationships
with GPs were becoming strained. The changing nature of symptoms
and the current appointment system within many GP practices
(same‐day appointments only for the most urgent cases) meant that
appointments were often held after symptoms had temporarily
resolved, aggravating the perception held by participants that they
were not believed by their GPs:
CHILTON ET AL. - 5
So I went and showed him. I insisted, because he didn’t
really want to see me. Too busy of course, then I said I
desperately need to see you and he said, well can’t we
do this over the phone, and I said, well I really want you
to see this because every time I tend to go, by the time
you get the appointment it’s gone down hasn’t it (Ian).
All of the participants recalled feeling that their GP had been
evasive about the possible cause of their symptoms, which could
cause a great deal of anxiety and frustration;
I turned up there [GP surgery] after telling him the
symptoms on the phone and he got a little book out
and started reading it and he’d got a list of the things
that it could possibly be and he said I can’t tell you
what they might be because I’d worry you to death,
and I thought Christ, what, just tell me. I mean, I felt
like getting the book off him and having a good look
see. You know if you start doing that, you start imag-
ining things that are wrong with you (Ian).
yes and I’d just had that one blood test back and I
went to see him and he said they had picked a
little something up. He was very cagey, he wouldn’t
say anything; he just picked up a little something
up, but this is alright, and that’s alright but there’s
a little something, and but the other levels are fine
you know. I felt like saying just tell me then
(Carol).
For some participants, their eventual referral was described as a
chance event, by seeing a GP with whom they formed a good rela-
tionship, or who was keen to listen, or who just happened to have
more experience in relation to patients with RA;
so that’s when I started to see Dr Jxxxxx by chance and
she was, you felt that she listened to you, you know,
and understood what you were going through and erm
(Doris),
but really you’re in the lap of the Gods a little bit aren’t
you, (George).
3.8 | Lost time
When reflecting on their journey to referral, some participants felt
that action should have been taken more quickly within Primary Care
and were left with a sense of having ‘lost time’ struggling with their
symptoms:
Slow in from the GP point of view, yes, I should have
been referred sooner (Alice).
I suppose on hind sight we (wife and George) hoped
it would have been picked up a lot quicker and by
now the process would have been to start the
medication. I think we have lost nearly 2 months
probably (George).
Well, they (GPs) should have referred me a lot sooner.
They should have really insisted. That I think you have
got this and you should have a test at the hospital.
That’s what I’d do to be fair (Ian).
4 | DISCUSSION
Experiences shared by participants with EI/RA in this study, high-
lighted several challenges faced within Primary Care. These chal-
lenges are not exclusive to patients but extend to family members as
well. Findings revealed that family and friends offer an important
hidden, influential shared network in guiding and encouraging par-
ticipants in the very early stages of their decision making to seek
professional help, as well as providing essential ongoing support at
times of concern and frustration.
Seeking support from family and friends when experiencing early
signs of EI/RA has also been reported (Sakalys, 1997; Shaul, 1995;
Stack et al., 2012). It offers insight into the shared and naturalistic
decision making (Klein, 2008); participants in this study used during
personal uncertainty pre‐consultation with their GP. As such, family
and friends become important partners in the journey to referral and
could provide support in reducing delays to early referral.
Participants in this study had to remain persistent in order to
achieve a referral to specialist services. Their ongoing and often
worsening symptoms provided some urgency and motivation in
encouraging them to continue to seek help from their GP. This was
despite their experiences of feeling disbelieved or dismissed by their
GPs. Although personal urgency has been previously identified as a
precursor to help seeking in other RA research (Bykerk & Em-
ery, 2010; Diederik et al., 2019; Molbaek et al., 2016; Simons
et al., 2017; Stack et al., 2012; Van der Linden, 2010); there has been
little recognition of the impact feeling disbelieved or dismissed has on
individuals attempting referral. Unlike other RA studies that have
reported reluctance by participants to seek help (Kumar et al., 2010;
Raciborski, 2017; Sheppard et al., 2008; Stack et al., 2019; Tiwana
et al., 2015), this study indicates a key feature of delay is a lack of GP
knowledge and apparent triviality assigned to participant reported
symptoms. This has only been identified by participants detailed
relational aspects of their experiences describing their persistence to
have symptoms resolved. Whilst previous studies indicate patients
attend GPs from four and up to ten times seeking help, before being
referred (Bykerk & Emery, 2010; Diederik et al., 2019; Stack
et al., 2019; The King’s Fund, 2009), this study revealed how par-
ticipants, who experienced symptoms for some time, reported repeat
visitations to GPs seeking answers in what became a joint endeavour
with family to resolve ongoing pain and incapacity.
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Participants faced difficulties when seeking consultations in a
timely manner with their preferred GP. Access to preferred GPs was
not always possible and often resulted in them being seen by unfa-
miliar GPs. This study identifies how a lack of continuity contributed
to inconsistencies in medical decisions and subsequent delayed
referral. Participants often attended an appointment with their GP
after symptoms had resolved, so the GP had to rely only on their
description/recollection of symptoms. There was a sense that GPs
were reluctant to refer until they had seen physical evidence of
symptoms (e.g., joint swelling) and would not refer on the basis of
patient description only. This could be contributing to delays in
referral, reducing opportunities for patients to see a specialist
Rheumatologist during the important ‘window of opportunity’ with
potentially longer‐term consequences for joint damage. In addition,
this delay prolonged the amount of time participants in this study had
to continue to live with their symptoms, often as their symptoms
worsened. The inconsistency in medical decisions, due in part to lack
of GP continuity, led to uncertainty and frustration for both partici-
pants and family in seeking a resolve to their pain and disability.
Being listened to, believed and understood are fundamental re-
quirements of patient‐centred care which did not appear to be
consistently experienced by participants in this study. Participants
perceived poor interpersonal relationships, unsympathetic attitudes,
behaviour and apparent limited understanding of their presenting
symptoms as barriers to being believed and understood. Participants
believed these barriers played an important role in delaying their
referral to specialist care. The recognition by participants of the ‘lost
opportunity’ of an early referral is a cause for concern. As patients
learn more about their condition, their sense of dissatisfaction in the
care received within Primary Care could grow. The limited reports of
any shared discussions between participants and their GPs in relation
to a referral decision suggests that attempts towards SDM were
minimal. Preliminary findings (not yet published) indicate by adopting
a SDM approach within Primary Care could reduce or prevent such
referral delays. Therefore, it is important to recognise those patients
attending the surgery several times with unresolved symptoms and
expedite referral for specialist opinion.
In this study patient symptomology was reported by some pa-
tients as horrendous, life changing and recognised as lost time. Some
reported symptoms ongoing for over 12 months despite seeking
medical assistance on several occasions. Whilst there is recognition
of the factors influencing delay and the frequency patients visit their
GP, there is limited evidence on the effects that a lack of GP conti-
nuity has on communications and sharing in early referral decisions
for patients presenting with EI/RA.
5 | STRENGTHS AND LIMITATIONS
Whilst this study cannot be representative of patients with EI/RA in
the wider rheumatology community, it has to be recognised, there
were as many medical practices as there were participants. Patients
would have been happy to have been interviewed longer than 1 h.
However, the limitations of interviewing participants no longer than
1 h were respected as stated in ethics application. If interviews had
been extended, it is possible more detailed narratives may have been
collected.
6 | CONCLUSION
This study highlights the experiences of seven EI/RA participants
who experienced delays in referral from Primary Care into Sec-
ondary Care. Participants reported that they didn’t feel listened to,
believed or understood and they associated this with their delays to
referral into Secondary Care. The consequences of this delay
extended from patients to their families, as patients relied on
support from their family members in order to pursue their referral.
Participants reflected on this as a period of great frustration and
perceived that this impacted on their relationship with their GP.
Given the physical, impact that delays to referral can have for those
with EI/RA, additional training and awareness raising amongst GPs
about the physical and psychological needs of this group, is
recommended.
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